CLASS II Drug recall · Reported 18 Sep 2019 · FDA Enforcement Report
Bevacizumab, 1.25 mg/ MJ Syringe Intravitreal Injection recalled
Pacifico National is recalling Bevacizumab, 1.25 mg/ MJ Syringe Intravitreal Injection, Single use only, distributed in Puerto Rico. The recall was initiated on 30 Aug 2019 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-1850-2019
- FDA event ID
- 83702
- Recalling firm
- Pacifico National, Melbourne, FL
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- 30 Aug 2019
- FDA classified
- 10 Sep 2019
- Reported
- 18 Sep 2019
- Type
- Voluntary: Firm initiated
- Customers notified by
- Press Release
- Reason category
- Sterility
- Drug class
- Injectable & IV Drugs
Timeline
| 30 Aug 2019 | Recall initiated by company | |
| 10 Sep 2019 | Classified by FDA | +11 days |
| 18 Sep 2019 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Lack of assurance of sterility.
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
Bevacizumab, 1.25 mg/0.05 mL, 31G MJ Syringe Intravitreal Injection, Single use only, Rx only, Repackaged by AmEx Pharmacy 1515 Elizabeth St. Suite J Melbourne, FL 32901
Where it was distributed
Continental U.S. and Puerto Rico
Questions about this recall
Why was it recalled?
Lack of assurance of sterility.
Which lots are affected?
All lots remaining within expiry.
Where was it sold?
Continental U.S. and Puerto Rico
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
1 other product · FDA event 83702This product is part of a recall event; the main page for the event is Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled.
| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| CLASS II | Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |
More recalls from Pacifico National
All 5| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab 1.25 mg/ MJ syringe Intravitreal Injection recalled | Pacifico National | Packaging Defects | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 1.25 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
| Drug | CLASS I | Avastin (Bevacizumab) 2 mg/ syringe recalled by Pacifico National | Pacifico National | Sterility | Nationwide |
Other Bevacizumab recalls
All 16| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Bevacizumab 1.75 mg/ - syringe, Intravitreal Total Volume recalled | RC Outsourcing | Sterility | Nationwide |
| Drug | CLASS II | Bevacizumab 1.25 MG/ Solution for Injection syringes recalled | Pine Pharmaceuticals | Sterility | Nationwide |
| Drug | CLASS III | Bevacizumab 2.5 mg/, Solution for Injection recalled | Pine Pharmaceuticals | Packaging Defects | Nationwide |
| Drug | CLASS II | Bevacizumab, 2.5 mg/, Norm-Ject Syringe Intravitreal recalled | Pacifico National | Sterility | PR |
| Drug | CLASS II | Bevacizumab 784 MG / Ns Ivpb recalled by Infusion Options | Infusion Options | Sterility | NY |